Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Stenehjem

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Blood Medicine|October 28, 2015
Panobinostat for the treatment of multiple myeloma: the evidence to dateHanna Bailey, David D Stenehjem, Sunil Sharma
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2022
Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemiaRebecca Pokorny, David D Stenehjem, Jeffrey A Gilreath
Journal of Pain & Palliative Care Pharmacotherapy|May 22, 2013
The pharmacoeconomics of breakthrough cancer painKuan-Ling Kuo, Surasak Saokaew, David D Stenehjem
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
Total dose iron dextran infusion in cancer patients: is it SaFe2+?Jeffrey A Gilreath, David D Stenehjem, George M Rodgers
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 15, 2016
Ceritinib: A primer for pharmacistsTrang H Au, Courtney C Cavalieri, David D Stenehjem
American Journal of Hematology|February 18, 2014
Diagnosis and treatment of cancer-related anemiaJeffrey A Gilreath, David D Stenehjem, George M Rodgers
Oncotargets and Therapy|October 3, 2018
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancerDavid D Stenehjem, Dao Tran, Michael A Nkrumah, et al.
Future Medicinal Chemistry|March 24, 2011
Novel and emerging strategies in drug delivery for overcoming the blood-brain barrierDavid D Stenehjem, Anika M S Hartz, Björn Bauer, et al.
Pharmacogenomics|January 20, 2021
Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinicJacob T Brown, Danielle MacDonald, Ann Yapel, et al.
Innovations in Pharmacy|May 19, 2021
Primary Care Clinicians Attitudes and Knowledge of Pharmacogenetics in a Large, Multi-state, Healthcare SystemMegan Olander, Stephen Waring, David D Stenehjem, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Blood Medicine|October 28, 2015
Panobinostat for the treatment of multiple myeloma: the evidence to dateHanna Bailey, David D Stenehjem, Sunil Sharma
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 8, 2022
Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemiaRebecca Pokorny, David D Stenehjem, Jeffrey A Gilreath
Journal of Pain & Palliative Care Pharmacotherapy|May 22, 2013
The pharmacoeconomics of breakthrough cancer painKuan-Ling Kuo, Surasak Saokaew, David D Stenehjem
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2012
Total dose iron dextran infusion in cancer patients: is it SaFe2+?Jeffrey A Gilreath, David D Stenehjem, George M Rodgers
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 15, 2016
Ceritinib: A primer for pharmacistsTrang H Au, Courtney C Cavalieri, David D Stenehjem
American Journal of Hematology|February 18, 2014
Diagnosis and treatment of cancer-related anemiaJeffrey A Gilreath, David D Stenehjem, George M Rodgers
Oncotargets and Therapy|October 3, 2018
PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancerDavid D Stenehjem, Dao Tran, Michael A Nkrumah, et al.
Future Medicinal Chemistry|March 24, 2011
Novel and emerging strategies in drug delivery for overcoming the blood-brain barrierDavid D Stenehjem, Anika M S Hartz, Björn Bauer, et al.
Pharmacogenomics|January 20, 2021
Integrating pharmacogenetic testing via medication therapy management in an outpatient family medicine clinicJacob T Brown, Danielle MacDonald, Ann Yapel, et al.
Innovations in Pharmacy|May 19, 2021
Primary Care Clinicians Attitudes and Knowledge of Pharmacogenetics in a Large, Multi-state, Healthcare SystemMegan Olander, Stephen Waring, David D Stenehjem, et al.
Pageof 5